论文部分内容阅读
目的观察左卡尼汀治疗不稳定型心绞痛(UAP)的临床疗效。方法选择UAP患者82例,随机分为2组:对照组常规给予硝酸盐制剂、β-受体阻滞剂或钙拮抗剂、低分子肝素;治疗组在常规治疗的基础上加用左卡尼汀3.0g静脉滴注1次/d治疗。结果治疗组与对照组相比,可改善胸闷、胸痛及乏力症状,能有效缓解心绞痛症状(P<0.01),心电图缺血性ST-T改善的有效率2组差异有统计学意义(P<0.05),无明显不良反应发生。结论传统药物辅以左卡尼汀是治疗UAP的一种安全有效的新方法,可能与改善缺血心肌的能量代谢有关。
Objective To observe the clinical efficacy of levocarnitine in the treatment of unstable angina pectoris (UAP). Methods Eighty-two UAP patients were randomly divided into two groups: the control group was given routine nitrates, β-blockers or calcium antagonists, and low molecular weight heparin. The treatment group was given ZUCC Ting 3.0g intravenous infusion 1 / d treatment. Results Compared with the control group, the treatment group improved the symptoms of chest tightness, chest pain and fatigue, relieved the symptoms of angina pectoris (P <0.01), and the effective rate of ischemic ST-T improvement was statistically significant (P < 0.05), no significant adverse reactions occurred. Conclusion Traditional Chinese medicine with L-carnitine is a safe and effective new method for the treatment of UAP, which may be related to improving the energy metabolism of ischemic myocardium.